Review Article| Volume 22, ISSUE 12, P2518-2526, December 2021

Download started.


The Impact of Pharmaceutical Care in Multidisciplinary Teams on Health Outcomes: Systematic Review and Meta-Analysis



      Pharmacists’ care has an essential role in multidisciplinary teams in charge of chronic patients. However, data available on the clinical outcomes of these activities appear inconclusive. This study aimed to systematically investigate the effect of multidisciplinary teams that include coordinated pharmaceutical care on clinical outcomes.


      Systematic review and meta-analysis. Relevant studies identified from MEDLINE, Cochrane, Web of Science, Scopus and CINAHL databases were analyzed. The search included randomized clinical trials published in 2000-2018. Included studies were all published studies in English that compared the effectiveness of multidisciplinary teams including pharmacist care to usual care. Meta-analysis was carried out using a random effects model, and subgroup analysis was conducted to determine the sources of heterogeneity.

      Setting and Participants

      29 studies involving 4186 adult patients were included.


      Follow-up time varied from 30 to 180 days. The most common primary endpoint was the frequency of hospitalizations or readmissions, followed by variation in clinical parameter variables related to quality of prescription, treatment adherence and costs.


      Twelve (41.3%) of the included studies scored low risk of bias according to the AMSTAR-2 scale, the remaining 17 (58.7%) being classified as intermediate risk. The intervention of a multidisciplinary team reduced the probability of readmission by 32% [odds ratio (OR) 0.74, 95% confidence interval (CI) 0.62-0.89]. Six of the 29 (20.7%) studies included met the inclusion criteria of the meta-analysis on quality-of-life outcomes. The intervention of the multidisciplinary team represented a significant increase in patients’ quality of life (OR 0.58, 95% CI 0.47-0.69). Analysis of heterogeneity showed a significant difference between the studies. No evidence of publication bias was identified.

      Conclusions and Implications

      Multidisciplinary programs that include pharmaceutical care reduce the risk of visiting hospitals and improve patients’ quality of life. This review supports the importance of the pharmacists as part of multidisciplinary teams.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of the American Medical Directors Association
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Koshman S.L.
        Pharmacist care of patients with heart failure: A systematic review of randomized trials.
        Arch Intern Med. 2008; 168: 687
        • Mekonnen A.B.
        • McLachlan A.J.
        • Brien J.A.
        Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: A systematic review and meta-analysis.
        BMJ Open. 2016; 6: e010003
      1. The third WHO Global Patient Safety Challenge: Medication without harm. Geneva: World Health Organization.
        (Available at:)
        • Wiedenmayer K.
        • Summers R.S.
        • Mackie C.A.
        • et al.
        Handbook – 2006 Edition.pdf.
        (Available at:)
        • Draguet V.
        A pharmaceutical strategy for Europe. Public Health—European Commission.
        (Available at:)
        Date: 2020
        Date accessed: November 23, 2020
        • Lazarou J.
        • Pomeranz B.H.
        • Corey P.N.
        Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies.
        JAMA. 1998; : 1200-1205
        • Baena M.I.
        • Fajardo P.C.
        • Pintor-Mármol A.
        • et al.
        Negative clinical outcomes of medication resulting in emergency department visits.
        Eur J Clin Pharmacol. 2014; 70: 79-87
        • Castro I.
        • Guardiola J.M.
        • Tuneu L.
        • et al.
        Drug-related visits to the emergency department in a Spanish university hospital.
        Int J Clin Pharm. 2013; 35: 727-735
        • Patel P.
        • Zed P.J.
        Drug-related visits to the emergency department: How big is the problem?.
        Pharmacotherapy. 2002; 22: 915-923
        • Nivya K.
        • Sri Sai Kiran V.
        • Ragoo N.
        • et al.
        Systemic review on drug related hospital admissions: A PubMed-based search.
        Saudi Pharm J. 2015; 23: 1-8
        • Dalleur O.
        • Beeler P.E.
        • Schnipper J.L.
        • et al.
        30-day potentially avoidable readmissions due to adverse drug events.
        J Patient Saf. 2021; 17: e379-e386
        • Kaboli P.
        • Hoth A.
        • McClimon B.
        • Schnipper J.
        Clinical pharmacists and inpatient medical care: A systematic review.
        Arch Intern Med. 2006; 166: 955-964
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • PRISMA Group
        Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement.
        PLoS Med. 2009; 6: e1000097
        • Shamseer L.
        • Moher D.
        • Clarke M.
        • et al.
        Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
        BMJ. 2015; 350: g7647
      2. [Unidad de pacientes pluripatológicos: estándares y recomendaciones]. Spanish ministry of health and social policy.
        (Available at:)
        • Higgins J.
        • Green S.
        Cochrane Handbook for systematic reviews of interventions. Cochrane Training.
        (Available at:)
        Date: 2008
        Date accessed: October 14, 2020
        • Higgins J.P.T.
        • Altman D.G.
        • Gøtzsche P.C.
        • et al.
        The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials.
        BMJ. 2011; 343: d5928
        • Zillich A.J.
        • Snyder M.E.
        • Frail C.K.
        • et al.
        A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients.
        Health Serv Res. 2014; 49: 1537-1554
        • Bonetti A.F.
        • Bagatim B.Q.
        • Mendes A.M.
        • et al.
        Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial. Clinics 2018;73.
        (Available at:)
        • Surgery and Pharmacy in Liaison (SUREPILL) Study Group
        Effect of a ward-based pharmacy team on preventable adverse drug events in surgical patients (SUREPILL study).
        Br J Surg. 2015; 102: 1204-1212
        • Leendertse A.J.
        • de Koning G.H.P.
        • Goudswaard A.N.
        • et al.
        Preventing hospital admissions by reviewing medication (PHARM) in primary care: An open controlled study in an elderly population.
        J Clin Pharm Ther. 2013; 38: 379-387
        • Dashti-Khavidaki S.
        • Sharif Z.
        • Khalili H.
        • et al.
        The use of pharmaceutical care to improve health-related quality of life in hemodialysis patients in Iran.
        Int J Clin Pharm. 2013; 35: 260-267
        • Gillespie U.
        • Alassaad A.
        • Henrohn D.
        • et al.
        A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: A randomized controlled trial.
        Arch Intern Med. 2009; 169: 894-900
        • Hogg W.
        • Lemelin J.
        • Dahrouge S.
        • et al.
        Randomized controlled trial of anticipatory and preventive multidisciplinary team care: for complex patients in a community-based primary care setting.
        Can Fam Physician Med Fam Can. 2009; 55: e76-e85
        • Jack B.W.
        • Chetty V.K.
        • Anthony D.
        • et al.
        A reengineered hospital discharge program to decrease rehospitalization: A randomized trial.
        Ann Intern Med. 2009; 150: 178-187
        • Makowsky M.J.
        • Koshman S.L.
        • Midodzi W.K.
        • et al.
        Capturing outcomes of clinical activities performed by a rounding pharmacist practicing in a team environment: The COLLABORATE study [NCT00351676].
        Med Care. 2009; 47: 642-650
        • Mateti U.V.
        • Nagappa A.N.
        • Attur R.P.
        • et al.
        Impact of pharmaceutical care on the health-related quality of life among hemodialysis patients: A multicenter randomized controlled study.
        Saudi J Kidney Dis Transplant. 2017; 28: 1293-1306
        • Painter J.T.
        • Fortney J.C.
        • Austen M.A.
        • et al.
        Cost-effectiveness of telemedicine-based collaborative care for posttraumatic stress disorder.
        Psychiatr Serv Wash DC. 2017; 68: 1157-1163
        • Pyne J.M.
        • Fortney J.C.
        • Tripathi S.P.
        • et al.
        Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
        Arch Gen Psychiatry. 2010; 67: 812-821
        • Sharp L.K.
        • Tilton J.J.
        • Touchette D.R.
        • et al.
        Community health workers supporting clinical pharmacists in diabetes management: A randomized controlled trial.
        Pharmacotherapy. 2018; 38: 58-68
        • Siaw M.Y.L.
        • Ko Y.
        • Malone D.C.
        • et al.
        Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): A randomized controlled trial.
        J Clin Pharm Ther. 2017; 42: 475-482
        • Sjölander M.
        • Lindholm L.
        • Pfister B.
        • et al.
        Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
        Res Soc Adm Pharm RSAP. 2019; 15: 287-291
        • Wathne J.S.
        • Kleppe L.K.S.
        • Harthug S.
        • et al.
        The effect of antibiotic stewardship interventions with stakeholder involvement in hospital settings: A multicentre, cluster randomized controlled intervention study.
        Antimicrob Resist Infect Control. 2018; 7: 109
        • Jarab A.S.
        • Alqudah S.G.
        • Khdour M.
        • et al.
        Impact of pharmaceutical care on health outcomes in patients with COPD.
        Int J Clin Pharm. 2012; 34: 53-62
        • Olesen C.
        • Harbig P.
        • Buus K.M.
        • et al.
        Impact of pharmaceutical care on adherence, hospitalisations and mortality in elderly patients.
        Int J Clin Pharm. 2014; 36: 163-171
        • Bell S.P.
        • Schnipper J.L.
        • Goggins K.
        • et al.
        Effect of pharmacist counseling intervention on health care utilization following hospital discharge: A randomized control trial.
        J Gen Intern Med. 2016; 31: 470-477
        • Lenander C.
        • Elfsson B.
        • Danielsson B.
        • et al.
        Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: A randomized controlled trial.
        Scand J Prim Health Care. 2014; 32: 180-186
        • Carrión J.A.
        • Gonzalez-Colominas E.
        • García-Retortillo M.
        • et al.
        A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
        J Hepatol. 2013; 59: 926-933
        • Casper E.A.
        • Wakeel L.M.E.
        • Saleh M.A.
        • et al.
        Management of pharmacotherapy-related problems in acute coronary syndrome: Role of clinical pharmacist in cardiac rehabilitation unit.
        Basic Clin Pharmacol Toxicol. 2019; 125: 44-53
        • Chen J.
        • Lu X.
        • Wang W.
        • et al.
        Impact of a clinical pharmacist-led guidance team on cancer pain therapy in China: A prospective multicenter cohort study.
        J Pain Symptom Manage. 2014; 48: 500-509
        • Cossette B.
        • Éthier J.F.
        • Joly-Mischlich T.
        • et al.
        Reduction in targeted potentially inappropriate medication use in elderly inpatients: A pragmatic randomized controlled trial.
        Eur J Clin Pharmacol. 2017; 73: 1237-1245
        • Wu W.C.
        • Taveira T.H.
        • Jeffery S.
        • et al.
        Costs and effectiveness of pharmacist-led group medical visits for type-2 diabetes: A multi-center randomized controlled trial.
        PLoS One. 2018; 13: e0195898
        • Karapinar-Çarkıt F.
        • van der Knaap R.
        • Bouhannouch F.
        • et al.
        Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital.
        PLoS One. 2017; 12: e0174513
        • Lin C.Y.
        • Yaseri M.
        • Pakpour A.H.
        • et al.
        Can a multifaceted intervention including motivational interviewing improve medication adherence, quality of life, and mortality rates in older patients undergoing coronary artery bypass surgery? A multicenter, randomized controlled trial with 18-month follow-up.
        Drugs Aging. 2017; 34: 143-156
        • Lai P.S.M.
        • Chua S.S.
        • Chan S.P.
        Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis.
        Int J Clin Pharm. 2013; 35: 629-637
        • Aljumah K.
        • Hassali M.A.
        Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: A randomised controlled study.
        BMC Psychiatry. 2015; 15: 219
        • Shea B.J.
        • Reeves B.C.
        • Wells G.
        • et al.
        AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
        BMJ. 2017; 358: j4008
        • Ware J.E.
        • Kosinski M.
        SF-36 physical & mental health summary scales: A manual for users of version 1.
        Quality Metric. 2001;
        • Pirmohamed M.
        • James S.
        • Meakin S.
        • et al.
        Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients.
        BMJ. 2004; 329: 15-19
        • Brockhattingen K.K.
        • Anru P.L.
        • Masud T.
        • et al.
        Association between number of medications and mortality in geriatric inpatients: A Danish nationwide register-based cohort study.
        Eur Geriatr Med. 2020; 11: 1063-1071
        • Hedna K.
        • Hakkarainen K.M.
        • Gyllensten H.
        • et al.
        Potentially inappropriate prescribing and adverse drug reactions in the elderly: A population-based study.
        Eur J Clin Pharmacol. 2015; 71: 1525-1533
        • Scott M.G.
        • Scullin C.
        • Hogg A.
        • et al.
        Integrated medicines management to medicines optimisation in Northern Ireland (2000-2014): A review.
        Eur J Hosp Pharm. 2015; 22: 222-228
        • Etchells E.
        • Koo M.
        • Daneman N.
        • et al.
        Comparative economic analyses of patient safety improvement strategies in acute care: A systematic review.
        BMJ Qual Saf. 2012; 21: 44856
        • Coleman E.A.
        • Berenson R.A.
        Lost in transition: Challenges and opportunities for improving the quality of transitional care.
        Ann Intern Med. 2004; 141: 533-536
        • Gilmore-Bykovskyi A.L.
        • Roberts T.J.
        • King B.J.
        • et al.
        Transitions from hospitals to skilled nursing facilities for persons with dementia: A challenging convergence of patient and system-level needs.
        Gerontologist. 2017; 57: 867-879
        • King B.J.
        • Gilmore-Bykovskyi A.L.
        • Roiland R.A.
        • et al.
        The consequences of poor communication during transitions from hospital to skilled nursing facility: A qualitative study.
        J Am Geriatr Soc. 2013; 61: 1095-1102
        • Kind A.J.
        • Jensen L.L.
        • Kennelty K.A.
        Far too easy: Opioid diversion during the transition from hospital to nursing home.
        J Am Geriatr Soc. 2014; 62: 2229-2231